Skip to main content
. 2016 Sep 27;3(1):28–36. doi: 10.1093/ehjcvp/pvw031

Figure 4.

Figure 4

Risk of major or CRNM bleeding for the reduced and standard dose of dabigatran, rivaroxaban, and apixaban compared with warfarin. Crude IR for first bleeding episode are given as events per 100 person-years. CI, confidence interval; CRNM, clinically relevant non-major bleeding; HR, adjusted hazard ratio; IR, incidence rate; OAC, oral anticoagulant.